Structural Mechanism of the Bromodomain of the Coactivator CBP in p53 Transcriptional Activation

Molecular Cell

Volumn 13, Issue 2, 2004, Pages 251-263

  Mujtaba, Shiraz ^a   He, Yan ^a   Zeng, Lei ^a   Yan, Sherry ^a   Plotnikova, Olga ^a   Sachchidanand, ^a   Sanchez, Roberto ^a   Zeleznik Le, Nancy J ^b   Ronai, Ze'ev ^a   Zhou, Ming Ming ^a  

^a NEW YORK UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; LYSINE; PROTEIN P21; PROTEIN P53;

ACETYLATION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G1 PHASE; DNA DAMAGE; EMBRYO; GENETIC CONSERVATION; MITOSIS INHIBITION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 10744233648     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00528-8     Document Type: Article

References (67)

1. Agalioti T., Chen G., Thanos D. Deciphering the transcriptional histone acetylation code for a human gene. Cell. 111:2002;381-392.
2. Alarcon-Vargas D., Ronai Z. p53-Mdm2 - the affair that never ends. Carcinogenesis. 23:2002;541-547.
3. Attardi L.D., Lowe S.W., Brugarolas J., Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15:1996;3693-3701.
4. Avantaggiati M.L., Ogryzko V., Gardner K., Giordano A., Levine A.S., Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell. 89:1997;1175-1184.
5. Ayton P.M., Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 20:2001;5695-5707.
6. Barlev N.A., Liu L., Chehab N.H., Mansfield K., Harris K.G., Halazonetis T.D., Berger S.L. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell. 8:2001;1243-1254.
7. Brown C.E., Howe L., Sousa K., Alley S.C., Carozza M.J., Tan S., Workman J.L. Recruitment of HAT complexes by direct activator interactions with the ATM-related Tra1 subunit. Science. 292:2001;2333-2337.
8. Brownell J.E., Allis C.D. Special HATs for special occasions. linking histone acetylation to chromatin assembly and gene activation Curr. Opin. Genet. Dev. 6:1996;176-184.
9. Brunger A.T. X-PLOR version 3.1. a system for X-Ray crystallography and NMR, version 3.1:1993;Yale University Press, New Haven, CT.
10. Carson M. Ribbons 2.0. J. Appl. Crystallogr. 24:1991;958-961.
11. Clore G.M., Gronenborn A.M. Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods Enzymol. 239:1994;349-363.
12. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., Zhou M.-M. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 399:1999;491-496.
13. Dorr A., Kiermer V., Pedal A., Rackwitz H.-R., Henklein P., Schubert U., Zhou M.-M., Verdin E., Ott M. Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J. 21:2002;2715-2733.
14. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
15. El-Deiry W.S., Tokino T., Waldman T., Oliner J.D., Velculescu V.E., Burrell M., Hill D.E., Healy E., Rees J.L., Hamilton S.R.et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55:1995;2910-2919.
16. Friedman J.R., Fredericks W.J., Jensen D.E., Speicher D.W., Huang X.P., Neilson E.G., Rauscher F.J. III. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 10:1996;2067-2078.
17. Fuchs S.Y., Adler V., Pincus M.R., Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA. 95:1998;10541-10546. a.
18. Fuchs S.Y., Fried V.A., Ronai Z. Stress-activated kinases regulate protein stability. Oncogene. 17:1998;1483-1490. b.
19. Giordano A., Avantaggiati M.L. p300 and CBP. partners for life and death J. Cell. Physiol. 181:1999;218-230.
20. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
21. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., Paolo Pandolfi P. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2:2000;730-736.
22. Hassan A.H., Prochasson P., Neely K.E., Galasinski S.C., Chandy M., Carrozza M.J., Workman J.L. Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell. 111:2002;369-379.
23. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
24. Haynes S.R., Dollard C., Winston F., Beck S., Trowsdale J., Dawid I.B. The bromodomain. a conserved sequence found in human, Drosophia and yeast proteins Nucleic Acids Res. 20:1992;2603.
25. Hudson B.P., Martinez-Yamout M.A., Dyson H.J., Wright P.E. Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. J. Mol. Biol. 304:2000;355-370.
26. Hupp T.R., Lane D.P. Allosteric activation of latent p53 tetramers. Curr. Biol. 4:1994;865-875.
27. Ito A., Lai C.H., Zhao X., Saito S., Hamilton M.H., Appella E., Yao T.P. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20:2001;1331-1340.
28. Ito A., Kawaguchi Y., Lai C.H., Kovacs J.J., Higashimoto Y., Appella E., Yao T.P. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21:2002;6236-6245.
29. Jacobson R.H., Ladurner A.G., King D.S., Tjian R. Structure and function of a human TAFII250 double bromodomain module. Science. 288:2000;1422-1425.
30. Jeanmougin F., Wurtz J.M., Douarin B.L., Chambon P., Losson R. The bromodomain revisited. Trends Biochem. Sci. 22:1997;151-153.
31. Ko L.J., Prives C. p53. puzzle and paradigm Genes Dev. 10:1996;1054-1072.
32. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
33. Kwok R.P., Laurance M.E., Lundblad J.R., Goldman P.S., Shih H., Connor L.M., Marriott S.J., Goodman R.H. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature. 380:1996;642-646.
34. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., Thornton J.M. Aqua and procheck-nmr. programs for checking the quality of protein structures solved by nmr J. Biomol. NMR. 8:1996;477-486.
35. Lavau C., Du C., Thirman M., Zeleznik-Le N. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J. 19:2000;4655-4664.
36. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
37. Li M., Luo J., Brooks C.L., Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 277:2002;50607-50611.
38. Liedman D., Zeleznik-Le N. Retroviral transduction model of mixed lineage leukemia fused to CREB binding protein. Curr. Opin. Hematol. 8:2001;218-223.
39. Lill N.L., Grossman S.R., Ginsberg D., DeCaprio J., Livingston D.M. Binding and modulation of p53 by p300/CBP coactivators. Nature. 387:1997;823-827.
40. Liu L., Scolnick D.M., Trievel R.C., Zhang H.B., Marmorstein R., Halazonetis T.D., Berger S.L. p53 sites acetylated in vitro by P/CAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19:1999;1202-1209.
41. Luo J., Su F., Chen D., Shiloh A., Gu W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature. 408:2000;377-381.
42. Manning E.T., Ikehara T., Ito T., Kadonaga J.T., Kraus W.L. p300 forms a stable, template-committed complex with chromatin. role for the bromodomain Mol. Cell. Biol. 21:2001;3876-3887.
43. Marmorstein R., Berger S.L. Structure and function of bromodomains in chromatin-regulating complexes. Gene. 272:2001;1-9.
44. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
45. Momand J., Zambetti G.P. Mdm-2. "big brother" of p53 J. Cell. Biochem. 64:1997;343-352.
46. Mujtaba S., He Y., Zeng L., Farooq A., Carlson J.E., Ott M., Verdin E., Zhou M.-M. Structural basis of lysine-acetylated HIV-1 Tat recognition by P/CAF bromodomain. Mol. Cell. 9:2002;575-586.
47. Nakamura S., Roth J.A., Mukhopadhyay T. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol. Cell. 20:2000;9391-9398.
48. Nilges M., O'Donoghue S. Ambiguous NOEs and automated NOE assignment. Prog. NMR Spectrosc. 32:1998;107-139.
49. Owen D.J., Ornaghi P., Yang J.C., Lowe N., Evans P.R., Ballario P., Neuhaus D., Eiletici P., Travers A.A. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 19:2000;6141-6149.
50. Pearson M., Carbone R., Sebastiani C., Cioce M., Fagioli M., Saito S., Higashimoto Y., Appella E., Minucci S., Pandolfi P.P.et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 406:2000;207-210.
51. Prives C., Hall P.A. The p53 pathway. J. Pathol. 187:1999;112-126.
52. Sakaguchi K., Herrera J.E., Saito S., Miki T., Bustin M., Vassilev A., Anderson C.W., Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:1998;2831-2841.
53. Sali A., Blundell T. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:1993;779-815.
54. Scolnick D.M., Chehab N.H., Stavridi E.S., Lien M.C., Caruso L., Moran E., Berger S.L., Halazonetis T.D. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:1997;3693-3696.
55. Sobulo O.M., Borrow J., Tomek R., Reshmi S., Harden A., Schlegelberger B., Housman D., Doggett N.A., Rowley J.D., Zeleznik-Le N.J. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23,p13.3). Proc. Natl. Acad. Sci. USA. 94:1997;8732-8737.
56. Sterner D.E., Grant P.A., Roberts S.M., Duggan L.J., Belotserkovskaya R., Pacella L.A., Winston F., Workman J.L., Berger S.L. Functional organization of the yeast SAGA complex. distinct components involved in structural integrity, nucleosome acetylation, and TATA-binding protein interaction Mol. Cell. Biol. 19:1999;86-98.
57. Tamkun J.W., Deuring R., Scott M.P., Kissinger M., Pattatucci A.M., Kaufman T.C., Kennison J.A. brahma. a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2 Cell. 68:1992;561-572.
58. Tang H.Y., Zhao K., Pizzolato J.F., Fonarev M., Langer J.C., Manfredi J.J. Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53. J. Biol. Chem. 273:1998;29156-29163.
59. Travers A. Chromatin modification. how to put a HAT on the histones Curr. Biol. 9:1999;23-25.
60. Vo N., Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276:2001;13505-13508.
61. Vogelstein B., Lane D., Levine M.J. Surfing the p53 network. Nature. 408:2000;307-310.
62. Wang Y., Prives C. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature. 376:1995;88-91.
63. Winston F., Allis C.D. The bromodomain. a chromatin-targeting module? Nat. Struct. Biol. 6:1999;601-604.
64. Yamazaki T., Lee W., Arrowsmith C.H., Mahandiram D.R., Kay L.E. A suite of triple resonance NMR experiments for the backbone assignment of 15N, 13C, 2H labeled proteins with high sensitivity. J. Am. Chem. Soc. 116:1994;11655-11666.
65. Yin Y., Liu Y.X., Jin Y.J., Hall E.J., Barrett J.C. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature. 422:2003;527-531.
66. Zeng L., Zhou M.-M. Bromodomain. an acetyl-lysine binding domain FEBS Lett. 513:2001;124-128.
67. Zhao R., Gish K., Murphy M., Yin Y., Notterman D., Hoffman W.H., Tom E., Mack D.H., Levine A.J. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14:2000;981-993.